These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35232264)

  • 1. Cellular immunotherapy in gastric cancer: adoptive cell therapy and dendritic cell-based vaccination.
    Faghfuri E; Shadbad MA; Faghfouri AH; Soozangar N
    Immunotherapy; 2022 Apr; 14(6):475-488. PubMed ID: 35232264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.
    Abozeid M; Rosato A; Sommaggio R
    Biomed Res Int; 2017; 2017():5791262. PubMed ID: 28781967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric cancer and the epoch of immunotherapy approaches.
    Niccolai E; Taddei A; Prisco D; Amedei A
    World J Gastroenterol; 2015 May; 21(19):5778-93. PubMed ID: 26019442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAR T‑cell therapy for gastric cancer: Potential and perspective (Review).
    Long B; Qin L; Zhang B; Li Q; Wang L; Jiang X; Ye H; Zhang G; Yu Z; Jiao Z
    Int J Oncol; 2020 Apr; 56(4):889-899. PubMed ID: 32319561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunotherapy in breast cancer: The quest for consistent biomarkers.
    Venetis K; Invernizzi M; Sajjadi E; Curigliano G; Fusco N
    Cancer Treat Rev; 2020 Nov; 90():102089. PubMed ID: 32889360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.
    Jiang JT; Shen YP; Wu CP; Zhu YB; Wei WX; Chen LJ; Zheng X; Sun J; Lu BF; Zhang XG
    World J Gastroenterol; 2010 Dec; 16(48):6155-62. PubMed ID: 21182234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient eradication of subcutaneous but not of autochthonous gastric tumors by adoptive T cell transfer in an SV40 T antigen mouse model.
    Bourquin C; von der Borch P; Zoglmeier C; Anz D; Sandholzer N; Suhartha N; Wurzenberger C; Denzel A; Kammerer R; Zimmermann W; Endres S
    J Immunol; 2010 Aug; 185(4):2580-8. PubMed ID: 20644173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Adoptive Immune-cell Therapy in Patients with Advanced Gastric Cancer: A Retrospective Study.
    Takimoto R; Kamigaki T; Okada S; Matsuda E; Ibe H; Oguma E; Naitoh K; Makita K; Goto S
    Anticancer Res; 2017 Jul; 37(7):3947-3954. PubMed ID: 28668899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive cell therapy for acute myeloid leukemia.
    Ma H; Padmanabhan Iyer S; Parmar S; Gong Y
    Leuk Lymphoma; 2019 Jun; 60(6):1370-1380. PubMed ID: 30628504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic advances in gastric cancer.
    Yoneda A; Kuroki T; Eguchi S
    Surg Today; 2021 Nov; 51(11):1727-1735. PubMed ID: 33590326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.
    Blair AB; Murphy A
    Curr Probl Cancer; 2018; 42(1):49-58. PubMed ID: 29501212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives.
    Abdul-Latif M; Townsend K; Dearman C; Shiu KK; Khan K
    Cancer Treat Rev; 2020 Aug; 88():102030. PubMed ID: 32505807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of adoptive cellular therapy in patients with gastric cancer: a meta-analysis.
    Shen D; Liu ZH; Xu JN; Xu F; Lin QF; Lin F; Mao WD
    Immunotherapy; 2016 Jul; 8(8):971-81. PubMed ID: 27381688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in gastric cancer.
    Matsueda S; Graham DY
    World J Gastroenterol; 2014 Feb; 20(7):1657-66. PubMed ID: 24587645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine strategies for glioblastoma: progress and future directions.
    Jackson C; Ruzevick J; Brem H; Lim M
    Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
    Dolcetti R; De Re V; Canzonieri V
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29844297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunotherapy for malignant gliomas.
    Lin Y; Okada H
    Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer.
    Wang Y; Wang C; Xiao H; Niu C; Wu H; Jin H; Yao C; He H; Tian H; Han F; Li D; Han W; Xu J; Chen J; Cui J; Li W
    Cancer Med; 2017 Jan; 6(1):45-53. PubMed ID: 27790867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immunotherapy with dendritic cells in cancer: current status.
    Nencioni A; Brossart P
    Stem Cells; 2004; 22(4):501-13. PubMed ID: 15277696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.